- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.06. | Moderna's mRNA RSV vaccine wins expanded FDA approval for younger adults | ||
| 13.06. | Debiopharm and Alkyon link for radioligand therapies development | ||
| 13.06. | FDA approves label expansion of AbbVie hepatitis C therapy | ||
| 12.06. | Vutrisiran marks first silencer approved for ATTR-CM | ||
| 12.06. | Enterome to advance EO2463 immunotherapy with $19m funding | ||
| 12.06. | Customs simplified: the need to streamline pharma shipments | ||
| 12.06. | Novo Nordisk signs $812m research deal with Deep Apple for non-GLP-1 drugs | ||
| 12.06. | FDA approves Capsida's CAP-003 gene therapy for Parkinson's | ||
| 12.06. | SpliceBio secures $135m for gene therapy development | ||
| 11.06. | Gilead hit with FDA clinical hold for batch of HIV trials | ||
| 11.06. | NHS to receive £29bn funding boost | ||
| 11.06. | Echosens and Boehringer expand partnership for MASH diagnosis | ||
| 11.06. | Trump's push to onshore pharma manufacturing clouded by 'lack of clarity' | ||
| 11.06. | Antares Therapeutics gains $177m for cancer medicines development | ||
| 11.06. | Outlook's wet AMD treatment accepted by SMC for NHS Scotland | ||
| 10.06. | Mosanna Therapeutics gains $80m to advance OSA nasal spray | ||
| 10.06. | RFK Jr axes vaccine advisory committee members | ||
| 10.06. | MSD receives FDA approval for Enflonsia to prevent RSV | ||
| 10.06. | EC approves Alnylam's vutrisiran for ATTR-CM treatment | ||
| 09.06. | FDA approves YolTech's YOLT-101 for familial hypercholesterolemia | ||
| 09.06. | Aytu BioPharma to commercialise Exxua for MDD in the US | ||
| 09.06. | The European Market Access Lag: 2021-2024 | ||
| 09.06. | EC approves AstraZeneca's acalabrutinib combo for CLL | ||
| 06.06. | SCHOTT Pharma invests in RTU cartridge capacity expansion | ||
| 06.06. | RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .